Becton Dickinson

Becton Dickinson (BD) is a global medical technology company that focuses on advancing the world of health. It offers innovative solutions to help healthcare providers, life science researchers, clinical laboratories, and the pharmaceutical industry improve patient outcomes, reduce costs, and increase access to healthcare. Its products and services span a wide range of medical disciplines, from medical and diagnostic imaging equipment to medical supplies, laboratory equipment, and medical consumables. BD also offers a range of services, such as biosafety consulting and clinical support.

1897 - Maxwell Becton and Fairleigh Dickinson, two businessmen from New York City, form Becton, Dickinson and Company (BD) to manufacture syringes and needles.

1904 - BD introduces the Luer-Lok syringe, which is designed to securely lock the needle onto the syringe, preventing it from coming off during use.

1924 - BD introduces the first sterile disposable syringe, which helps to prevent the spread of infections in healthcare settings.

1940 - BD begins manufacturing plastic products, including test tubes and petri dishes, which become popular in scientific research and medical laboratories.

1953 - BD introduces the Vacutainer blood collection system, which uses a vacuum tube and needle to draw blood from a patient.

1961 - BD introduces the first automated blood culture system, which speeds up the process of detecting bacterial infections in blood samples.

1972 - BD introduces the first automated microbiology system, which uses computerized technology to analyze and identify microorganisms in clinical samples.

1988 - BD acquires Immunicon Corporation, a company that develops and manufactures diagnostic tests for cancer and other diseases.

1997 - BD celebrates its 100th anniversary as a company.

2000 - BD acquires the medical devices division of Pfizer Inc., expanding its portfolio of products for medical and surgical procedures.

2015 - BD announces plans to acquire CareFusion Corporation, a medical technology company specializing in patient care solutions and medical devices, in a $12.2 billion deal.

2020 - BD plays a major role in the global response to the COVID-19 pandemic, manufacturing and distributing diagnostic tests, medical equipment, and other products to help healthcare providers care for patients.

To make healthcare and patient experiences safer, more efficient, and more effective through our products, services, and solutions.

We strive to be a leading healthcare and life sciences company in the world through reimagined care delivery, sustainable health outcomes and corporate social responsibility.

Medical Supplies and Devices: BD offers a wide range of medical supplies and devices, including needles and syringes, IV catheters, safety-engineered devices, wound care products, and sharps disposal systems.

Diagnostics: BD offers a variety of diagnostic solutions, including laboratory equipment, reagents, and instruments for infectious disease testing, hematology, and chemistry.

Life Sciences: BD offers products and services for the life sciences industry, including labware, cell and tissue culture, and liquid handling systems.

Medication Management: BD offers a range of medication management solutions, including medication management systems, infusion pumps, and medication safety systems.

Women's Health: BD offers a variety of products and services for women's health, including cervical cancer screening, bone density testing, and gynecological surgery.

Diabetes Care: BD offers a range of diabetes care products, including insulin delivery devices, glucose monitoring systems, and lancing devices.

Biosciences: BD offers a range of products and services for the biosciences industry, including sample collection and preparation, microorganisms and cell culture, and reagents.